A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin®) for treatment of basal cell carcinoma

Lasers in Surgery and Medicine

Volumn 38, Issue 5, 2006, Pages 417-426

  Oseroff, Allan R ^a   Blumenson, Leslie R ^b   Wilson, B Dale ^a   Mang, Thomas S ^c   Bellnier, David A ^a   Parsons, John C ^a   Frawley, Noreen ^a   Cooper, Michele ^a   Zeitouni, Nathalie ^a   Dougherty, Thomas J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Biostatistical Consulting Services   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Basal cell carcinoma; PDT; Porfimer sodium

Indexed keywords

ANTIBIOTIC AGENT; PHOTOFRIN; PHOTOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RECURRENCE; DOSE RESPONSE; DYE LASER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; SKIN CARCINOMA; SUN EXPOSURE; SUNBURN; TREATMENT OUTCOME; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; DIHEMATOPORPHYRIN ETHER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 33745699954     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20363     Document Type: Article

References (41)

1. Wong CS, Strange RC, Lear JT. Basal cell carcinoma. BMJ 2003;327:794-798.
2. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002;146(Suppl 61):1-6.
3. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976;36:2326-2331.
4. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905.
5. Biel M. Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope 1998;108:1259-1268.
6. Edell ES. Photodynamic therapy for bronchogenic carcinoma. Curr Opin Pulm Med 1998;4:205-206.
7. Nseyo U, Shumaker B, Klein E, Sutherland K. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma-in-situ of the bladder. J Urol 1998;160:39-44.
8. Wilson BD, Mang TS, Cooper M, Stoll H. Use of photodynamic therapy for the treatment of extensive basal cell carcinomas. Facial Plast Surg 1990;6:185-189.
9. Jones CM, Mang T, Cooper M, Wilson BD, Stoll HL. Photodynamic therapy in the treatment of Bowen's disease. J Amer Acad Dermtol 1992;27:979-982.
10. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905.
11. McCaughan JS, Jr., Guy JT, Hicks WM, Laufman L, Nims TA, Walker J. Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms. Arch Surg 1989;124: 211-216.
12. Pennington DG, Waner M, Knox A. Photodynamic therapy for multiple skin cancers. Plast Reconstrct Surg 1988;82: 1067-1071.
13. Wilson BD, Mang TS, Stoll H, Jones C, Cooper M, Dougherty TJ. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Derm 1992;128:1597-1601.
14. Patterson MS, Wilson BC, Graff R. In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine. Photochem Photobiol 1990;51:343-349.
15. Potter WR, Mang TS, Dougherty TJ. The theory of photodynamic therapy dosimetry: Consequences of photodestruction of sensitizer. In: Kessel D, editor. Selected Papers on Photodynamic Therapy. Bellingham: SPIE; 1993. pp 387-391.
16. Mang TS, Dougherty TJ, Potter WR, Boyle DG, Somer S, Moan J. Photobleaching of porphyrins used in photodynamic therapy and implications for therapy. Photochem Photobiol 1987;45:501-506.
17. Bellnier DA, Wood LM, Potter WR, Weishaupt KR, Oseroff AR. Design and construction of a light delivery system for photodynamic therapy. Med Phys J 1999;26: 1552-1558.
18. Swanson N. Mohs' surgery; Technique, indications, applications, and the future. Arch Dermatol 1983;119:761-773.
19. Lightdale CJ. Role of photodynamic therapy in the management of advanced esophageal cancer. Gastrointest Endosc Clin N Am 2000;10:397-408.
20. McCaughan JS, Guy JT, Hicks W, Laufman L, Nims TA, Walker J. Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms. Arch Surg 1989;124:211-216.
21. Pennington DG, Waner M, Knox A. Photodynamic therapy for multiple skin cancers. Plast Reconstr Surg 1988;82;1067-1071.
22. Zeitouni NC, Shieh S, Oseroff AR. Laser and photodynamic therapy in the management of cutaneous malignancies. Clin Dermat 2001;19:328-338.
23. McCaughan JSJ, Guy JT, Hicks W, Laufman L, Nims TA, Walker J. Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms. Arch Surg 1989;124:211-216.
24. Mang TS, Dougherty TJ, Potter WR, Boyle DG, Somer S, Moan J. Photobleaching of porphyrins used in photodynamic therapy and implications for therapy. Photochem Photobiol 1987;45:501-506.
25. Oseroff AR, Shieh S, Frawley NP, Cheney R, Blumenson LE, Pivnick EK, Bellnier DA. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol 2005;141:60-67.
26. Babilas P, Karrer S, Sidoroff A, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology-An update. Photodermatol Photoimmunol Photomed 2005;21:142-149.
27. Vinciullo C, Elliott T, Francis D, Gebauer K, Spelman L, Nguyen R, Weightman W, Sheridan A, Reid C, Czarnecki D, Murrell D. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 2005;152:765-772.
28. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: Outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 2003;19:134-141.
29. Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes LE, Kaufmann R, de Rie M, Legat FJ, Stender IM, Soler AM, Wennberg AM, Wong GA, Larko O. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003;149:1242-1249.
30. Zeitouni NC, Oseroff AR, Shieh S. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol Immunol 2003;39:1133-1136.
31. Zeitouni NC, Shieh S, Oseroff AR. Laser and photodynamic therapy in the management of cutaneous malignancies. Clin Dermatol 2001;19:328-338.
32. Leman J, Morton C, Mackie R. Treatment of superficial basal cell carcinoma with topical photodynamic therapy: Recurrence rates and outcome. Br J Derm 2001;145(Suppl.59):17.
33. Morton C, Whitehurst C, McColl JH, Moore JV, MacKie R. Photodynamic therapy for large or multiple patches of Bowen Disease and basal cell carcinoma. Arch Dermatol 2001;137: 319-324.
34. Morton C, Brown S, Collins S, Ibbotson S, Jenkinson H, Kurwa H, Langmack K, McKenna K, Moseley H, Pearse AD, Stringer M, Taylor DK, Wong G, Rhodes LE. Guidelines for topical photodynamic therapy: Report of a workshop of the British Photodermatology Group. Br J Derm 2002;146:552-567.
35. Cappugi P, Campolmi P, Mavilia L, Prignano F, Rossi R. Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: A mini review. J Chemother 2001;13:494-502.
36. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolavevulinate-based photodynamic therapy alone with prior curettage. Br J Derm 2001;145:467-471.
37. Haller JC, Cairnduff F, Slack G, Schofield J, Whitehurst C, Tunstall R, Brown SB, Roberts DJ. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 2000; 143:1270-1275.
38. Rhodes LE, de Rie M, Enstrom Y, Groves R, Morken T, Goulden V, Wong GA, Grob JJ, Varma S, Wolf P. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: Results of a multicenter randomized prospective trial. Arch Dermatol 2004;140:17-23.
39. Morton CA, MacKie RM, Whitehurst C, Moore JV, McColl JH. Photodynamic therapy for basal cell carcinoma: Effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 1998;134:248-249.
40. Baert L, Berg R, Van Damme B, D'Hallewin MA, Johansson J, Svanberg K, Svanberg S. Clinical fluorescence diagnosis of human bladder carcinoma following low-dose Photofrin injection. Urology 1993;41:322-330.
41. Bellnier DA, Greco WR, Nava H, Loewen GM, Oseroff AR, Dougherty TJ. Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. Cancer Chemother Pharmacol 2006;57:40-45.